Posterior Cortical Atrophy (PCA) in Corticobasal Syndrome represents a rare but well-recognized phenotypic variant in which patients present with the characteristic asymmetric cortical features of CBS combined with prominent visual processing deficits reminiscent of PCA. This variant highlights the anatomical overlap between the parietal-occipital regions affected in both conditions and provides important insights into disease localization and progression patterns in the 4R tauopathies.
This variant is distinct from CBS with comorbid Alzheimer's disease pathology, as PCA in CBS typically reflects the characteristic parietal-occipital involvement pattern of corticobasal degeneration rather than AD-related posterior cortical dysfunction.
Patients with CBS-PCA overlap maintain the classic corticobasal syndrome presentation:
- Asymmetric onset — symptoms begin on one side and remain more pronounced ipsilaterally
- Cortical signs — ideomotor apraxia, cortical sensory loss, alien limb phenomenon
- Extrapyramidal features — rigidity, bradykinesia, dystonia
- Myoclonus — present in approximately 40-60% of cases
The CBS-PCA variant includes features typical of posterior cortical involvement:
- Simultanagnosia — inability to perceive more than one object at a time
- Optic ataxia — misreaching for visual targets despite intact motor strength
- Oculomotor apraxia — difficulty initiating voluntary saccades
- Visual field defects — often contralateral to the more affected hemisphere
- Agnosia — failure to recognize familiar objects or faces despite intact vision
The combination of simultanagnosia, optic ataxia, and oculomotor apraxia constitutes Balint's syndrome, which may develop in severe CBS-PCA cases. This reflects bilateral parietal-occipital dysfunction and indicates advanced disease involvement of both hemispheres.
Left hemisphere parietal involvement may produce:
- Agraphia — writing difficulty
- Acalculia — calculation impairment
- Finger agnosia — inability to identify fingers
- Left-right disorientation — confusion with directional concepts
¶ Epidemiology and Prevalence
- Frequency: CBS-PCA variant accounts for approximately 5-10% of all CBS cases
- Onset: Similar to typical CBS (mean age 60-68 years)
- Sex distribution: Variable reports, possibly slight female predominance
- Disease duration: Similar to typical CBS (median 6-8 years)
The CBS-PCA variant reflects early and prominent involvement of the posterior cortical regions typically affected in both CBD and PCA:
| Brain Region |
Function Affected |
Clinical Manifestation |
| Superior parietal lobule |
Visuospatial processing |
Simultanagnosia |
| Inferior parietal lobule |
Object recognition |
Visual agnosia |
| Occipital cortex |
Basic visual processing |
Visual field defects |
| Dorsal stream (MT/MST) |
Motion perception |
Optic ataxia |
| Frontal eye fields |
Saccade initiation |
Oculomotor apraxia |
Post-mortem studies of CBS-PCA cases demonstrate:
- Prominent tau pathology in parietal and occipital cortices
- Relative sparing of primary visual cortex (V1) early in disease
- Distribution pattern distinct from both typical CBS and typical PCA
- Astrocytic plaques characteristic of CBD in affected regions
The CBS-PCA variant differs from primary posterior cortical atrophy in several important ways:
| Feature |
CBS-PCA |
Primary PCA |
| Core CBS features |
Present from onset |
Absent initially |
| Symmetry |
Asymmetric |
Often symmetric |
| Motor features |
Prominent early |
Develop later |
| Pathology |
Typically CBD |
Usually AD |
The CBS-PCA variant should be suspected when:
- Patient meets criteria for corticobasal syndrome
- Prominent visual processing deficits present early (within first 2 years)
- Neurological exam reveals simultanagnosia, optic ataxia, or oculomotor apraxia
- Imaging demonstrates parietal-occipital atrophy extending beyond typical CBS pattern
- Asymmetric parietal-occipital atrophy — more pronounced on the clinically affected side
- Posterior cingulate involvement — often prominent
- Relative sparing of frontal motor regions early in disease
- Progressive involvement toward bilateral posterior regions with disease advancement
- Hypometabolism in parietal-occipital regions
- Asymmetric pattern reflecting clinical asymmetry
- Relative preservation of frontal motor cortex compared to typical CBS
- Distinct from PCA pattern which tends to be more symmetric
- Increased retention in parietal-occipital regions
- Pattern differs from both typical CBS and typical AD
- Useful for differential diagnosis from CBS due to AD pathology
Typical corticobasal syndrome presents with prominent motor and cortical signs but lacks the early visual processing deficits seen in the CBS-PCA variant.
Primary PCA typically presents with:
- Symmetric visual processing deficits
- Relative preservation of motor function initially
- Common underlying AD pathology
- Development of CBS features late in disease course
CBS due to underlying AD pathology may present with posterior cortical deficits, but:
- Memory impairment typically precedes visual symptoms
- Motor features may be less prominent
- Biomarkers show amyloid positivity
An umbrella term that includes both primary PCA and CBS-PCA variants.
Treatment approaches mirror those for typical CBS with additional considerations:
- Visual rehabilitation — orientation and mobility training
- Environmental modifications — reduce visual complexity
- Occupational therapy — adaptation strategies for simultanagnosia
- Assistive devices — visual aids and adaptive technology
Current clinical trials for CBS include the CBS-PCA variant:
- Tau-targeting therapies may be particularly relevant
- Patient selection for trials may benefit from biomarker characterization
- Disease progression: Similar rate to typical CBS
- Functional outcome: Additional disability from visual deficits
- Life expectancy: Median 6-8 years from symptom onset
- Mortality: Often related to falls, aspiration, or complications of immobility
- Tau PET imaging to characterize pathology distribution
- CSF biomarkers to assess co-pathology
- Neurofilament light chain for progression monitoring
- Inclusion of CBS-PCA in trials targeting posterior cortical involvement
- Outcome measures capturing visual processing deficits
- Further characterization of tau strain in CBS-PCA
- Relationship to CBD vs. PSP pathology distribution